Company Filing History:
Years Active: 2019-2024
Title: Innovations of Aeri Kim: A Leader in Pharmaceutical Patents
Introduction: Aeri Kim, based in Seoul, South Korea, is a distinguished inventor known for his significant contributions to the pharmaceutical industry. With a remarkable portfolio of seven patents, his innovations are paving the way for advancements in drug formulations and treatments.
Latest Patents: Aeri Kim's recent patents include a novel crystalline form of 1-(5-(2,4-Difluorophenyl)-1-((3-fluorophenyl)sulfonyl)-4-methoxy-1H-pyrrol-3-yl)-N-methylmethanamine salt. This invention presents various crystalline forms, including crystalline form I and II of hydrochloride, succinate, tartrate, and fumarate. These innovative crystalline forms boast high solubility in water and exceptional stability under moisture-proof and high-humidity conditions, making them suitable for pharmaceutical applications.
Career Highlights: Aeri Kim currently works with Daewoong Pharmaceutical Co., Ltd., where he applies his extensive knowledge and expertise to develop groundbreaking pharmaceutical solutions. His dedication to innovation and quality has positioned him as a prominent figure in the field, contributing significantly to the advancement of medication stability and efficacy.
Collaborations: Throughout his career, Aeri Kim has collaborated with esteemed colleagues, including Kwan Hyung Cho. Together, they work on developing innovative approaches to drug formulation, enhancing therapeutic outcomes through their collective expertise and research.
Conclusion: Aeri Kim's impressive accomplishments and commitment to innovation are evident in his extensive patent portfolio. His work at Daewoong Pharmaceutical Co., Ltd. exemplifies his dedication to improving pharmaceutical products for better patient care and treatment efficacy. As the pharmaceutical industry continues to evolve, inventors like Aeri Kim play a crucial role in shaping the future of healthcare through their groundbreaking inventions.